Navigation Links
Tight Blood Sugar Control Won't Help Babies After Heart Surgery
Date:9/10/2012

By Serena Gordon
HealthDay Reporter

FRIDAY, Sept. 7 (HealthDay News) -- Tightly controlling blood sugar levels after young children's heart surgery doesn't reduce the risk of infection, length of hospital stay or death, according to new research.

By keeping blood sugar levels in a normal range using insulin after surgery, researchers had hoped to see a reduction in infections and other complications. Instead, they saw an increased risk of dangerously low blood sugar levels.

"I think in the pediatric cardiac population, the question of whether or not tight glycemic control provides a benefit has been answered," said the study's lead author, Dr. Michael Agus, director of the medicine critical care program at Boston Children's Hospital. He said it's clear from this study that there's no statistically significant benefit to this therapy, and a clear risk from it.

Results of the study were published online Sept. 7 in the New England Journal of Medicine to coincide with a presentation at a pediatric critical care meeting in Santa Monica, Calif.

During a critical illness or a surgical procedure, blood sugar levels in the body rise, sometimes dramatically. For a long time, it was assumed this was a natural response to the stress of illness or surgery. What wasn't clear was whether these high blood sugar levels provided a benefit, such as giving the body extra fuel to fight off an infection, or if they were causing harm.

What was known was that people who had high blood sugar levels often had bad outcomes, such as higher rates of infection and death, according to Agus. In 2001, a single-center trial of people in the intensive care unit reported that lowering blood sugar levels with insulin resulted in dramatic reductions in bad outcomes, Agus said.

Since that time, larger studies have shown no benefit from lowering blood sugar levels to normal in the adult intensive care population. However
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
2. Infection Might Raise Blood Clot Risk for Older Adults: Study
3. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
4. Common Blood Pressure Drug Safe for Heart Failure: Study
5. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
6. High Blood Pressure May Be Especially Lethal for Blacks
7. Changes in gene expression may help explain high blood pressure in pregnancy
8. Researchers Develop Blood Test for Depression
9. Naturopathic care can improve blood sugar, mood in diabetes
10. Diabetes Groups Issue New Guidelines on Blood Sugar
11. Exercise May Help Patients With High Blood Pressure Live Longer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tight Blood Sugar Control Won't Help Babies After Heart Surgery
(Date:7/22/2014)... 2014 The Latin America Drilling fluid and ... and completion fluid market in Latin America with analysis and ... in Latin America is estimated to grow from around $0.93 ... CAGR of 9.2%, for the given period. , Browse through ... fluid Market Report, to get an idea of the in-depth ...
(Date:7/22/2014)... The donation from the Edusei Foundation was greatly appreciated by ... of strategic engineering, such assistance tends to etch good memories ... It provided a sense of family to them, which the ... Foundation donated various amounts of; milk, soap, frytol, sugar, ... Government of Ghana established the Kumasi Children’s Home in 1965 ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion fluid Market ... market in Middle East with analysis and forecast of revenue. ... is estimated to grow from around $560 million in 2013 ... for the given period. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/22/2014)... 22, 2014 According to ... Market Research “Circulating Circulating Tumor Cells (CTCs) ... (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) ... Optical Methods) and Applications: Prostate Cancer, Breast ... Industry Analysis, Size, Share, Growth, Trends and ...
(Date:7/22/2014)... Carlsbad, CA (PRWEB) July 22, 2014 ... 0% financing for 24 months on all models during ... 18th-28th. , Please visit http://www.d1spas.com/financing for ... leader in hydrotherapy, Dimension One Spas offers a wide ... your fingertips including lights, fountains, waterfalls, music, customizable massage, ...
Breaking Medicine News(10 mins):Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 3Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 4
... a recent research, drinking cola can lead to brittle bones ... the carbonated drink women consumed, the weaker// were their bones. ... advised not to drink too much of cola. The phosphoric ... drinks, is assumed to be responsible for the problem. ...
... Health Organization (WHO) for the first time issued Global Air ... air pollution that kills 2 million// people each year with ... ,The WHO appealed to governments to enhance air quality in ... in Manila revealed that almost 3,00,000 lives could be saved ...
... to cause deaths in women in developing countries is ... of deaths caused// because of uncontrolled bleeding following childbirth ... and studies conducted by researchers from the University of ... Institutes of Health . The studies have come to ...
... on the Indonesian resort island of Bali were in stable ... case, but so far they are stable," Wayan Sutarga, director ... Denpasar, told DPA., ,"We are still examining the babies, ... said, adding that in medical terms the girls are thoraco ...
... National Osteoporosis Foundation has estimated that nearly 55 percent ... osteoporosis, a disease of porous and brittle bones// that ... beverage among Americans has been found to contribute to ... studies conducted by Katherine Tucker, PhD, director of the ...
... C has become the scourge of multitude of Queenslanders, with ... disease//, underlining the importance of early medical intervention in the ... by a virus that targets the liver, which can also ... rolled out figures that show the alarming rise of Hepatitis ...
Cached Medicine News:Health News:Cola increases risk of Osteoporosis!! 2Health News:A Safe Drug For Safe Delivery 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 3
(Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
(Date:7/22/2014)... ALBANY, New York , July 22, 2014 ... published by Transparency Market Research "Process Spectroscopy Market (Technology Types ... infrared (FT-IR) spectroscopy) Market - Global Industry Analysis, Size, Share, ... valued at USD 714.5 million in 2012 and is expected ... 2019. North America was ...
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3
... Millennium: The Takeda Oncology,Company today reported ... III clinical trials of VELCADE based combinations ... previously untreated,multiple myeloma (MM). Prolonged progression-free survival ... and dexamethasone (VcD) with vincristine,adriamycin and dexamethasone ...
... 8 Alexion Pharmaceuticals,Inc. (Nasdaq: ... AEGIS, an open-label,registration study examining Soliris(R) (eculizumab) ... (PNH). The pre-specified,primary efficacy endpoint of change ... reduction (P<0.001). Key secondary endpoints including fatigue,(P<0.001) ...
Cached Medicine Technology:Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
... not restricted to small central fields, ... are full field capable, all encompassing ... you'll ever need to ensure the ... They also include the most important ...
... an innovative device designed to be a ... abdominal aortic aneurysms (AAA). It is constructed ... an outer self-expanding Nitinol support structure to ... The function of the endoprosthesis is to ...
... to remove a cast from an arm or ... patients are cut or burned by the cast ... professionals to remove any cast with confidence. This ... cuts and burns from the cast saw and ...
... creation of a vascular access, a correctly ... the utmost importance in many vascular procedures. ... seeking a high-precision tunneling instrument. The unique ... twisting or kinking for more accurate graft ...
Medicine Products: